Oman Ventricular Assist Device Market By Type, By Application and By Design – Opportunities & Forecast, 2018-2025
Oman Ventricular Assist Device Market, By Type (Left Ventricular Device, Right Ventricular Device and Biventricular Device), By Application (Bridge-to-transplant (BTT), Bridge-to-recovery (BTR) and Destination Therapy) and By Design (Implantable Ventricular Assist and Transcutaneous Ventricular Assist Devices) – Opportunities & Forecast, 2018-2025
As per GMI Research, the market for the Oman Ventricular Assist Device Market is estimated at USD xx million in 2018, and is projected to each USD xx million by 2025, growing at a CAGR of 8.1% during 2018-2025.
Factors fuelling the growth of the market are increasing incidence of heart diseases and rise in the number of patients waiting for heart transplant. Moreover, technological advancements in the design of product and increasing awareness regarding benefits of the cardiac devices are likely to accelerate the growth of Oman Ventricular Assist Device market during the forecasted period.
Left Ventricular Assist device lead the market during 2018-2025
Left Ventricular Assist Device segment is expected to hold the maximum revenue share in Oman during the forecast period. The highest growth rate is also predicted to be exhibited by LVAD segment due to the growing adoptions of these device among healthcare practitioners in Oman. Additionally, increase in awareness is expected to drive the growth of Ventricular Device Assist Market in the forecasted period.
Transcutaneous Ventricular Assist Device segment is predicted to have the highest growth rate in the market during 2018-2025.
The Implantable Ventricular Assist Devices segment held the maximum revenue share in 2017 owing to non-availability of heart donors whereas the Transcutaneous Ventricular Assist segment is expected to have the highest growth rate in the forecast period because of the lower rate of thrombus formation and blood trauma. Modifications in VADs were done to improve efficiency and durability
Various notable players operating in Oman Ventricular Assist Device Market include Berlin Heart GmbH, ABIOMED, Inc., Astrazeneca Plc, Bahwan Medical Supplies, Arabian Medical Devices, Surgitech Equipment LLC, Samiya Group, Taiba Pharma, Al Farsi Medical Supplies and Salalah Medical Supplies Manufacturing Company.
The Oman Ventricular Assist Device market has been segmented on the basis of Type, Application, and Design Segmentation. Based on Type, the market comprises of Left Ventricular Device, Right Ventricular Device and Biventricular Device. The Application type includes Bridge-to-transplant (BTT), Bridge-to-recovery (BTR) and Destination Therapy and the Design type includes Implantable Ventricular Assist and Transcutaneous Ventricular Assist Devices
The research report “Oman Ventricular Assist Device Market” provides in-depth analysis of the Ventricular Assist Device market, in Oman, based on application type, design type and type for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for Ventricular Assist Device Market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.
Key questions answered in this research report:
1- At what pace is the Ventricular Assist Device market growing in Oman? What will be the growth trend in future?
2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the coming years?
3- What are the various application areas and how they are poised to grow?
Why GMI Research
